Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Por Spencer, Andrew, Roberts, Andrew, Kennedy, Nola, Ravera, Christina, Cremers, Serge, Bilic, Sanela, Neeman, Terry, Copeman, Michael, Schran, Horst, Lynch, Kevin
Publicado em 2008

American Association of Pharmaceutical Scientists National Biotechnology Conference Short Course: Translational Challenges in Developing Antibody-Drug Conjugates: May 24, 2012, San...

Por Thudium, Karen, Bilic, Sanela, Leipold, Douglas, Mallet, William, Kaur, Surinder, Meibohm, Bernd, Erickson, Hans, Tibbitts, Jay, Zhao, Hong, Gupta, Manish
Publicado em 2013

Compartmental Pharmacokinetic Analysis of Oral Amprenavir with Secondary Peaks

Por Okusanya, Olanrewaju, Forrest, Alan, DiFrancesco, Robin, Bilic, Sanela, Rosenkranz, Susan, Para, Michael F., Adams, Elizabeth, Yarasheski, Kevin E., Reichman, Richard C., Morse, Gene D.
Publicado em 2007

Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia

Por Byrd, John C., Kipps, Thomas J., Flinn, Ian W., Cooper, Maureen, Odenike, Olatoyosi, Bendiske, Jennifer, Rediske, John, Bilic, Sanela, Dey, Jyotirmoy, Baeck, Johan, O'Brien, Susan
Publicado em 2012

Preparing Pharmacy Graduates for Traditional and Emerging Career Opportunities

Por Brazeau, Gayle A., Meyer, Susan M., Belsey, Michele, Bednarczyk, Edward M., Bilic, Sanela, Bullock, Julie, DeLander, Gary E., Fiese, E.F., Giroux, Stephen L., McNatty, Danny, Nemire, Ruth, Prescott, William A., Traynor, Andrew P.
Publicado em 2009

Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction

Por Huet, Heather A, Growney, Joseph D, Johnson, Jennifer A, Li, Jing, Bilic, Sanela, Ostrom, Lance, Zafari, Mohammad, Kowal, Colleen, Yang, Guizhi, Royo, Axelle, Jensen, Michael, Dombrecht, Bruno, Meerschaert, Kris RA, Kolkman, Joost A, Cromie, Karen D, Mosher, Rebecca, Gao, Hui, Schuller, Alwin, Isaacs, Randi, Sellers, William R, Ettenberg, Seth A
Publicado no MAbs (2014)

Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies

Por Ettenberg, Seth A., Charlat, Olga, Daley, Michael P., Liu, Shanming, Vincent, Karen J., Stuart, Darrin D., Schuller, Alwin G., Yuan, Jing, Ospina, Beatriz, Green, John, Yu, Qunyan, Walsh, Renee, Li, Sharon, Schmitz, Rita, Heine, Holger, Bilic, Sanela, Ostrom, Lance, Mosher, Rebecca, Hartlepp, K. Felix, Zhu, Zhenping, Fawell, Stephen, Yao, Yung-Mae, Stover, David, Finan, Peter M., Porter, Jeffery A., Sellers, William R., Klagge, Ingo M., Cong, Feng
Publicado em 2010